Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Whole-Brain Radiation Therapy With Thalidomide And Temozolomide in Brain Metastases
NCT00049361Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of thalidomide and temozolomide in brain metastasis (BM), sponsored by Wake Forest University Health Sciences. Primary endpoint: Overall Survival. Started Jan 2004; status: completed.
02
Drugs
thalidomidetemozolomide
03
Conditions
brain metastasis (BM)
Beyond the preview
Go deeper on NCT00049361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049361.